Incorporating Patient Perspectives into Structured Benefit-Risk Assessment: A Drug Development Framework Recommendation

Therapeutic Innovation & Regulatory Science 2026

View at publisher

Authors: Emuella M. Flood, Niklas Karlsson, Jennifer Ostridge, Bistra Kirova, Tim Sullivan, Gyorgy Zorenyi, Barbara Valastro, Jiyoon Park

DOI: 10.1007/s43441-026-00940-0

Cited by: 0

References: 16

Fields of Study & Subjects

Health Systems Economic Evaluations Quality of Life Statistical Methods in Clinical Trials Pharmaceutical studies and practices

References 16